Andere Sprachen Syngene International Limited

Aktien

A14YDD

INE398R01022

SYNGENE

Biotechnologie

Markt geschlossen - NSE India S.E. Andere Börsenplätze 12:05:04 13.02.2026			% 5 Tage	Veränd. 1. Jan.
434,35 ^INR	-2,69 %		-2,97 %	-33,28 %

06.02.	Excelsoft Technologies Limited kündigt Veränderungen im Vorstand an	CI
23.01.	Syngene International Limited passt Gewinnprognose für das Jahr 2025 an	CI

Andere Sprachen

06.02.	Excelsoft Technologies Limited Announces Executive Changes
23.01.	Syngene International Limited Revises Earnings Guidance for the Year 2025
22.01.	Syngene International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
22.01.	Syngene International Ltd Dec-quarter Consol Profit 150 Million Rupees
22.01.	Diary-India economic, corporate events on January 22
05.11.	Syngene International Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
05.11.	Syngene International Sept-quarter consol profit 671 million rupees
20.10.25	Orocidin A/S Develops Novel cGMP Manufacturing Process in Collaboration with Syngene
20.08.25	Syngene International Limited Announces Executive Changes
23.07.25	Syngene International Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
23.07.25	Syngene International Limited Appoints Chethan Yogesh as the Company Secretary and Compliance Officer, Effective Date from July 23, 2025
23.07.25	Syngene International June-quarter consol profit 867 mln rupees
16.06.25	Syngene Gets Voluntary Action Indicated Classification from US FDA for Biocon Park Facility
13.06.25	Syngene International Gets Establishment Inspection Report From USFDA
31.05.25	O2 Renewable Energy Ii Private Limited announced that it has received INR 65 million in funding from Syngene International Limited
23.04.25	Syngene International Limited announces Annual dividend, payable on August 22, 2025
23.04.25	Syngene International Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
01.04.25	Syngene International Limited Appoints Peter Bains as Chief Executive Officer
28.03.25	Syngene International Says National Faceless Assessment Centre Drops Penalty Proceedings For 33.6 Million Rupees
24.03.25	O2 Renewable Energy Ii Private Limited announced that it expects to receive INR 65 million in funding from Syngene International Limited
20.03.25	Syngene International Unit Completes $36.5 Million Acquisition of US Biologics Site
19.03.25	Emergent BioSolutions Completes Sale of Baltimore-Bayview Facility to Syngene International
19.03.25	Emergent Biosolutions finalizes sale of Baltimore-Bayview manufacturing site to Syngene International
11.03.25	Syngene International to Invest Up to $56 Million in US Subsidiary
10.03.25	Syngene International To Invest Up To USD 56 Million In Syngene USA

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Syngene International Limited

Aktien

A14YDD

INE398R01022

SYNGENE

Biotechnologie

Andere Sprachen

Filter